Notice ID: 844ee0dcdc254c77940fd7279d01e96fSpecial Notice
Services to Develop Antibodies against ESKAPEE Pathogens_NOI_to_Sole Source
Archived on August 7, 2020. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM UTC−04:00
- Posted
- July 8, 2020
- Notice type
- Special Notice
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 325414: Biological Product (except Diagnostic) Manufacturing
- Agency
- Department of WarDepartment of the Army
Notice details
- Office
- W4PZ USA MED RSCH ACQUIS ACT
- Place of performance
- Silver Spring, MD, 20910
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- W81XWH20R0082
- Notice ID
- 844ee0dcdc254c77940fd7279d01e96f
Description
THIS IS A RESEARCH AND DEVELOPMENT NOTICE OF INTENT TO SOLE SOURCE, NOT A REQUEST FOR PROPOSAL. Notice of Intent to Sole Source Only and shall not be construed as a solicitation or as an obligation on the part of Walter Reed Army Institute of Research (WRAIR) or the US Army Medical Research Acquisition Activity (USAMRAA). WRAIR is seeking a Small Business designated source that has the knowledge, capabilities, and technical expertise to provide the support services to develop antibodies against the ESKAPEE pathogens. The NAICS Code(s) in consideration for this requirement is 325414, the PSC of AN11. The objective of this requirement is to provide antibodies against protein targets found on the surface of ESKAPEE pathogens for research and testing in WRAIRs in vitro assays and animal models of infection. SCOPE: The attached draft Performance Work Statement (PWS) defines the procurement of the technical expertise and support services to develop antibodies against the ESKAPEE pathogens in support of the Wound Infections Department (WID), Bacterial Diseases Branch (BDB) at WRAIR. The contractor shall secure the provisions necessary to meet the specified objectives and perform the tasks described in attached draft PWS. To meet the objectives, the contractor shall provide antibodies against protein targets found on the surface of ESKAPEE pathogens for research and testing in WRAIRs in vitro assays and animal models of infection. PERIOD OF PERFORMANCE: The estimated period of performance would be: Base 30 September 2020 29 September 2021 (Total Contract will be Base and Four (4) 1 Year Options through September 2025). WORK SCHEDULE AND LOCATION All work associated with this effort shall be performed and completed at the contractor's facilities following the contractor's work hours and schedule. QUALITY STANDARDS Performance and Quality Standards will be outlined in the attach Quality Assurance Surveillence Plan. This requirement is defined as code 325414 under the North American Industry Classification System (NAICS). THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS. Responsible, interested parties may identify their interest by submitting capability information, by deadline specified to Major Kate Hamilton at kathleen.e.hamilton4.mil@mail.mil. Supporting evidence must be furnished in sufficient detail to demonstrate the firms ability to provide the stated capability. Responses will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, USAMRAA will proceed with the sole source contract.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
W81XWH20R0082- Special NoticeCurrentJul 8, 2020
Services to Develop Antibodies against ESKAPEE Pathogens_NOI_to_Sole Source
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
| - | Awarded | Open | |
NOTICE OF INTENT – SOLE-SOURCE ACQUISITION Notice No.: The National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS), intends to award a Firm-Fixed-Price Purchase Order to Creative Biolab Inc. for culture all cells and differentiate them, expand their cell populations to more than 20 million, collect them, verify cell count, and send them back to us. Description of the Requirement The primary objective of this study is to sequence and analyze the 4q35 locus on Chromosome 4 for several years. This locus is a gene-poor and extremely long (>100K) region of DNA that consists of many repetitive sequences which makes sequencing and analysis extremely difficult. To sequence this locus using Nanopore Sequencing technology. To expand the number of samples for our experiment, we looked for a company that can handle numerous cell lines and follow the protocol that we provide. Creative Biolabs is the only company/research institute that has been able to perform differentiation within 3 months and has the ability to follow our protocol with numerous cell lines. Justification for the Proposed Sole-Source Acquisition The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Only Creative Biolabs was willing to follow our exact protocol and had the logistical capacity to handle the large number of cell lines that we need to analyze, which is vital to research at the National Institute of Environmental Health Sciences. Response Information This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required preventive maintenance and remedial repair services for the specified instrument and meet all applicable technical and operational requirements. The Government will review timely submissions to determine whether another responsible source is capable of satisfying the requirement and whether a competitive acquisition is appropriate. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement. Capability statements must be submitted electronically to verne.griffin@nih.gov no later than 9:00 a.m. EDT on November 13, 2026. Please reference Notice No. 75N98027Q00053 in the subject line of the submission. | - | Pre-Solicitation | 11/12/2026 |
SAM.gov SOURCES SOUGHT NOTICE Solicitation Number: 75N98027Q00029 Title: Tau radiotracers for Baltimore Longitudinal Study of Aging Classification Code: 6505 NAICS Code: 325414 Description: Biological Product (except Diagnostic) Manufacturing This is a Small Business Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. Background: The BLSA was initiated in 1958 and is a multi-disciplinary study of physiologic and psychologic aspects of normal aging in community-dwelling men and women. Since 1994, we have been conducting a longitudinal brain imaging study of selected older adults in the BLSA to characterize individual differences in longitudinal brain changes, to investigate the extent to which these brain changes underlie individual differences in cognitive aging, to identify brain changes that may be predictors of cognitive decline and Alzheimer’s disease (AD), and to assess the impact of potential modulators of brain and cognitive aging. More recently, we have been collecting in vivo measures of brain amyloid and tau, the hallmark pathologies of AD, using PET scanning. The purpose of this acquisition is to acquire FDA- approved second generation tau PET imaging radioligand to perform in vivo Positron Emission Tomography (PET) scans to measure brain tau neuropathology in BLSA participants on a combined PET/computed tomography (CT) scanner. Purpose and Objectives: The purpose of this acquisition is to procure Tau radiotracers for the Baltimore Longitudinal Study of Aging. Project requirements: Independently, and not as an agent of the Government, the Contractor shall provide the following Lantheus products: 70 Tau radioligand doses for the base period. Catalog Number [18F]MK-6240. 70 Tau radioligand doses for option period 1. Catalog Number [18F]MK-6240. 70 Tau radioligand doses for option period 2. Catalog Number [18F]MK-6240. Anticipated period of performance: Base Year: November 18, 2026 – November 17, 2027 Option Year 1: November 18, 2027 – November 17, 2028 Option Year 2: November 18, 2028 – November 17, 2029 Requested Response: The intent of this sources sought notice is to define the procurement strategy (e.g. set-aside, sole source, unrestricted) for a solicitation that is intended to be posted soon. Interested contractors are requested to respond by (1) identifying how their proposed product meets or exceeds the project requirements listed above; and (2) providing product literature, white papers, or capability statements that demonstrate their bona fide ability to supply such an item within the time frame described above. In addition, please state your business size status and whether you are the manufacturer or authorized distributor of the item you propose. Please note that NIH is particularly interested in small business sources. If you are a small business, please state the type of small business (small business; HUBZone; service-disabled, veteran-owned; 8(a); veteran-owned; woman-owned; or small disadvantaged businesses) and your size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. The respondent must also provide their DUNS number, organization name, address, point of contact, and size and type of business (e.g., 8(a), HubZone, etc.), pursuant to the applicable NAICS code and any other information that may be helpful in developing or finalizing the acquisition requirements. The information submitted must be must be in an outline format that addresses each of the elements of the project requirements and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required. The response must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses. All responses to this notice must be submitted electronically to the Contracting Officer. Facsimile responses are NOT accepted. The response must be submitted to Kevin Alvarez, Contracting Officer, at e-mail address kevin.alvarez@nih.gov. The response must be received on or before October 27, 2026, 9:00am, Eastern Time. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published at SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). | - | Market Research | 10/27/2026 |
Award to furnish all of Washington Aqueducts Quicklime in accordance with specifications. | - | Awarded | Open |
This requirement is for Caustic Soda chemical buy. For those who are interested, please click the following link to UNISON marketplace: https://marketplace.unisonglobal.com/fbweb/fbobuyDetails.do?token=olwZ17axw%2F1s4%2F16Ct3liTWZgM4R1cqbzaAS40%2FGxWoZBg0PR4McIasi%2FnTMLB2r | - | Combined Synopsis | 04/01/2026 |
Additional Details
Solicitation Number
W81XWH20R0082
Archive Date
Aug 7, 2020
Office Address
FORT DETRICK, MD, 21702-5014